aua
eau,aua靶向治疗新信息
•肿瘤原发灶伴腔静脉癌栓 •局部复发病灶 •转移病灶 . . . 但需要个体化治疗 靶向药物新辅助治疗尚需前瞻性研究以明确其作用 靶向治疗评估 sunitnib治疗后分子标志物 77% of the response could be predicted: if VEGF difference was observed, 80% of patients had clinical